Treatment News:

• MS abre sindicância para apurar irregularidades na fila de transplantes (20/janeiro/2004)
• ABRALE e ABRASTA apresentaram "Projeto Nacional para Transplante de Medula Óssea - 2004"
  (07/novembro/2003)
• Reports in Public Health (29/setembro/2003)
• ABRASTA brings to patients the latest news on thalassemia treatment (September 11/2003)
• Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron
  concentrations and ventricular function in beta-thalassaemia (June 05/2003)
• Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with
  transfusion-dependent beta-thalassemia (June 05/2003)
• Deferiprone versus Deferoxamine in Patients with Thalassemia Major: A Randomized Clinical Trial
  (June 05/2003)
• Role of deferiprone in chelation therapy for transfusional iron overload (June 05/2003)
• The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients
  (June 05/2003)
• Ferriprox scientific monograph, only oral chelator for thalassaemia treatment. (September 12/2002)
• Summary of the 12a Conference on Oral Chelation - Greece (August 12/2002)
• New medication approved for Thalassaemia treatment in Brazil (August 2nd /2002)
• Blood Transfusion Therapy in ß-Thalassaemia Major (March 22nd /2002)

Visit also:

• Events Agenda
• International Events